Revenue | ₹1,717.22Cr |
Net Profits | ₹154.38Cr |
Net Profit Margins | 8.99% |
Alembic Pharmaceuticals Ltd’s revenue jumped 9.79% since last year same period to ₹1,717.22Cr in the Q1 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -3.73% fall in its revenue since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit jumped 14.6% since last year same period to ₹154.38Cr in the Q1 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -1.6% fall in its net profits since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit margin jumped 4.39% since last year same period to 8.99% in the Q1 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 2.22% jumped in its net profit margins since last 3-months.
The revenue for Alembic Pharmaceuticals Ltd in the Q1 results 2025 was ₹1,717.22Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q1 results 2025 was ₹154.38Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q1 results 2025 was 8.99%.
The revenue for Alembic Pharmaceuticals Ltd in the Q1 results 2024 was ₹1,564.15Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q1 results 2024 was ₹134.71Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q1 results 2024 was 8.61%.